BioTelemetry Technology ApS: Financial statements 2020
CVR: 37552534
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
BioTelemetry Technology ApS (CVR 37552534) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -124,455 and a net result of DKK -1,137,196 compared with DKK 796,167 the year before. Equity in the 2020 report amounted to DKK 15,309,275. The solvency ratio was 52.3%.
- Gross Profit
- DKK -124,455
- Profit/Loss
- DKK -1,137,196
- Equity
- DKK 15,309,275
- Total Assets
- DKK 29,274,932
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -124 t. | -1.1 mio. | 15.3 mio. | - |
| 2019 | - | 412 t. | 796 t. | 16.4 mio. | 0 |
| 2018 | - | -1 mio. | -698 t. | 15.7 mio. | 0 |
| 2017 | - | -2.5 mio. | -15.2 mio. | 16.3 mio. | - |
Official annual report
How creditworthy is BioTelemetry Technology ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
BioTelemetry Technology ApS has published its annual report for 2019. Gross profit came to DKK 411,920, and the net result was DKK 796,167.
About BioTelemetry Technology ApS
BioTelemetry Technology ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2016. The company has been dissolved on 20 December 2023. The company was registered under the industry Fremstilling af bestrålingsudstyr og elektromedicinsk og elektroterapeutisk udstyr. The company has 0 employees (2018). In 2022, the company reported a gross profit of DKK -115,998 and a net result of DKK -92,258 compared with DKK -126,560 the year before. Equity in the 2022 report amounted to DKK 15,090,457.